Metastatic breast cancer is an urgent priority for BCRF researchers as the leading cause of breast cancer deaths. While it can be treated—with more therapies and drugs available now than ever before—metastatic breast cancer remains incurable.
You are here
The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.
Tag:
Metastatic Research x
This year marks the 50th anniversary of the National Cancer Act, which declared our country’s “war on cancer.” It also marks 10 years since the passing of Evelyn H.
Up to 45 percent of patients with metastatic breast cancer develop brain metastases, and those who do have an average survival of three to 23 months.
We have made tremendous gains against breast cancer. Since BCRF’s founding in 1993, breast cancer mortality rates in the U.S. have declined by 40 percent.
For Carol, running has been a way of life. She started at the age of 13, and nothing has stopped her from hitting the pavement – including when she was diagnosed with metastatic breast cancer.
BCRF-Supported Study Finds Nigerian Women at Higher-Risk for Late-Stage and Inherited Breast Cancers
A BCRF-supported study, recently published in the Journal of Clinical Oncology, used genome sequencing to study the DNA of Nigerian women and found they are more likely to develop and die from triple n
Hormone Receptor Positive Breast Cancer: CDK4/6 inhibitors
BCRF previously reported on updates of a new class of drugs called CDK4/6 inhibitors in clinical trials for hormone receptor positi
Metastasis is a complicated process with many steps, beginning with the breast cancer cells breaking away from the primary tumor and entering the blood or lymphatic system. Not every tumor cell that that enters the circulation, however will form a tumor somewhere else in the body.
SABCS Thursday Highlights